Why 90% of clinical drug development fails and how to improve it?
Ninety percent of clinical drug development fails despite implementation of many successful strategies, which raised the question whether certain aspects in target validation and drug optimization are overlooked? Current drug optimization overly emphasizes potency/specificity using structure‒activit...
Saved in:
Main Authors: | Duxin Sun (Author), Wei Gao (Author), Hongxiang Hu (Author), Simon Zhou (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Why are we failing on health equity and how can we do better in future?
by: Gavin Mooney
Published: (2012) -
Aerosol Therapy in Asthma-Why We Are Failing Our Patients and How We Can Do Better
by: Robert W. Morton, et al.
Published: (2020) -
The unmet promise of trustworthy AI in healthcare: why we fail at clinical translation
by: Valerie K. Bürger, et al.
Published: (2024) -
Tumor-derived exosomes: Nanovesicles made by cancer cells to promote cancer metastasis
by: Hongwei Chen, et al.
Published: (2021) -
Why are we failing to promote physical activity globally?
by: Philipe de Souto Barreto
Published: (2013)